Brett Wilson Carter MD, Presenter: Author, Reed Elsevier Consultant, St. Jude Medical, Inc

Marcelo Kuperman Benveniste MD, Abstract Co-Author: Nothing to Disclose

Sonia Liliana Betancourt Cuellar MD, Abstract Co-Author: Nothing to Disclose

Patricia Monique de Groot MD, Abstract Co-Author: Nothing to Disclose

James Sorensen, Abstract Co-Author: Nothing to Disclose

John Peter Lichtenberger MD, Abstract Co-Author: Author, Amirsys, Inc.

Gerald F. Abbott MD, Abstract Co-Author: Author, Thieme Medical Publishers, Inc Author, Amirsys, Inc

1. Neoplasms of the chest wall account for approximately 2% of all thoracic malignancies. 2. Although chest wall tumors may be initially identified on chest radiography, they are best evaluated with advanced cross-sectional imaging studies such as MDCT, MRI, and PET/CT. 3. Malignant osseous and soft tissue tumors of the chest wall demonstrate key features across multiple imaging modalities. 4. Utilization of clinical and radiologic information enables the generation of focused differential diagnoses. 

1. Role of thoracic imaging in the evaluation of chest wall neoplasms Purpose of imaging Imaging modalities Imaging approach to chest wall tumors  Incomplete border sign  2. Classification system of chest wall neoplasms Osseous Tumors Soft Tissue Tumors 3. Key radiologic and clinical features of malignant chest wall tumors  4. Treatment of chest wall neoplasms  

http://abstract.rsna.org/uploads/2014/14004005/14004005_jpri.pdf

Carter, B, Benveniste, M, Betancourt Cuellar, S, de Groot, P, Sorensen, J, Lichtenberger, J, Abbott, G, Breaking Down the Wall: Malignant Neoplasms of the Chest Wall and Distinguishing Imaging Features.  Radiological Society of North America 2014 Scientific Assembly and Annual Meeting, - ,Chicago IL. http://archive.rsna.org/2014/14004005.html